Skip to main content
ACA health plan enrollmentACA Open EnrollmentACA premium tax creditsACA subsidiesemployersHealth CoverageHealth Plan EnrollmentMedicare health coveragePremium Insurance Assistance Program

When Access to Lifesaving HIV Medication is at Risk: What Florida’s ADAP Cuts Mean for Public Health

February 4, 2026

In early 2026, changes to Florida’s AIDS Drug Assistance Program (ADAP) introduced new challenges for individuals living with HIV and the clinics that serve them. ADAP plays a critical role in supporting access to life-sustaining HIV medications and related care, particularly for individuals who face financial or insurance barriers.

Who Is Affected… And How Many?

Under the new ADAP rules, Florida has sharply tightened eligibility and eliminated key benefits:

  • Income eligibility for uninsured clients has been reduced from 400% of the federal poverty level (~$62,600/year) to 130% (~$20,345/year). This means many individuals who previously qualified for help are now excluded.

  • Insurance premium assistance – which helped people afford health insurance that covered their HIV care – has been eliminated entirely.

According to the National Alliance of State and Territorial AIDS Directors (NASTAD), these changes would leave more than 16,000 Floridians currently enrolled in ADAP without coverage under the new criteria – roughly half of the people who depended on the program for uninterrupted access to HIV medications.

Why These Numbers Matter

For people living with HIV, maintaining consistent access to antiretroviral therapy isn’t optional, it’s essential. When treatment is continuous:

  • Viral load remains suppressed, significantly reducing the risk of disease progression and serious illness.

  • People living with HIV who are virally suppressed cannot sexually transmit the virus, which is a cornerstone of public health efforts to end the epidemic.

When treatment is interrupted, even briefly, there are measurable risks:

  • Viral rebound can occur, reducing health outcomes and increasing the likelihood of transmission.

  • Gaps in medication can lead to drug resistance and limited future treatment options.

Changes that disrupt this stability don’t just affect individual patients, they strain clinics and systems designed to help people stay in care.

Additional Concerns: Medication Access and Formulary Restrictions

Beyond eligibility and premium support, some advocacy groups have raised concerns that Florida’s ADAP changes may also impact access to certain HIV medications or restrict which regimens are covered under the program.

For patients stabilized on specific treatment plans, formulary disruptions introduce yet another layer of clinical risk and uncertainty.

Challenges for Clinics and Providers

Ryan White clinics and community health providers, which deliver essential services for people living with HIV, are now faced with the difficult task of helping patients find alternative coverage paths in a fragmented insurance landscape. With the elimination of premium assistance and tighter eligibility thresholds, clinics must:

  • Identify and enroll patients into new insurance coverage options.

  • Support patients through transitions to avoid lapses in treatment.

  • Manage additional administrative overhead during an already challenging period.

Growing Public Response and Legal Challenge

In recent weeks, these ADAP cuts have prompted widespread concern from HIV advocates, providers, and community organizations across Florida. Public protests and strong warnings from advocacy groups underscore the life-and-death consequences of disrupted access to care.

In addition, the AIDS Healthcare Foundation (AHF) has filed a lawsuit against the Florida Department of Health, arguing that the state implemented these ADAP changes without following the required formal rule-making process under Florida law. The legal challenge seeks to halt or delay the cuts before they take effect.

At this time, reporting indicates that unless altered through litigation or further administrative action, the new eligibility rules are still expected to begin March 1, 2026, leaving clinics and patients with limited time to prepare.

American Exchange is Here to Support You

At American Exchange, we recognize the strain these changes place on providers and patients alike. That’s why we’re actively supporting Florida Ryan White clinics as they help patients navigate the impact of ADAP changes.

American Exchange serves as Florida’s ADAP enrollment partner, working closely with clinics to help maintain access to health insurance coverage when traditional pathways are disrupted. Our Premium Insurance Assistance Program (PIAP) is designed to:

  • Assist with enrollment into appropriate insurance coverage options for patients at risk of coverage loss.

  • Manage premium and cost-sharing support where funding allows, reducing financial barriers for patients.

  • Reduce administrative workload for clinic staff during coverage transitions.

  • Help ensure continuity of care for individuals impacted by changes to ADAP.

We know that each clinic’s circumstances, budgets, and patient needs are unique. Our goal is to serve as a trusted partner as you assess options and protect access during this period of change.

Schedule time to meet with the American Exchange team here.

 

Sources used: